Envoy Medical (COCH) Change in Account Payables (2021 - 2026)
Envoy Medical (COCH) reported Change in Account Payables of -$1.2 million for Q1 2026, down 12300.0% on a YoY basis from N/an in Q1 2025, and down 396.12% sequentially from $412000.0 in Q4 2025.
Envoy Medical (COCH) Change in Account Payables (2021 - 2026) Analysis & Trends
Envoy Medical (COCH) has 6 years of Change in Account Payables data on file, last reported at -$1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 12300.0% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at $155000.0 (down 75.47% YoY), and the FY2025 full-year result was $1.4 million, up 7389.47% from the prior year.
- Change in Account Payables declined to -$1.2 million in Q1 2026, from $412000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.6 million in Q3 2023 to a low of -$3.4 million in Q4 2023.
- A 5-year average of $40647.1 and a median of $168000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 2435.05% in 2023 and plunged 12300.0% in 2026, its largest moves.
- Tracing COCH's Change in Account Payables over 5 years: stood at $235000.0 in 2022, then tumbled by 1567.66% to -$3.4 million in 2023, then soared by 93.56% to -$222000.0 in 2024, then soared by 285.59% to $412000.0 in 2025, then sank by 396.12% to -$1.2 million in 2026.
- Business Quant data shows COCH's Change in Account Payables at -$1.2 million in Q1 2026, $412000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | 412,000.00 |
| Dec 31, 2025 | 412,000.00 |
| Sep 30, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | -43,000.00 |
| Jun 30, 2025 | -43,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 676,000.00 |
| Jun 30, 2024 | 676,000.00 |
| Mar 31, 2024 | -641,000.00 |
| Mar 31, 2024 | -641,000.00 |
| Dec 31, 2023 | -3.45 Mn |
| Dec 31, 2023 | -3.45 Mn |